RELIEF THERAPEUTICS Holding SA Announces an Out-Licensing Agreement with H&H Group

GENEVA, Switzerland–(BUSINESS WIRE)–RELIEF THERAPEUTICS Holding SA (“Relief”, “the Company”) announces that it has concluded a licensing and co-development agreement (the “Agreement”) with Health and Happiness (H&H) Hong Kong Limited (“H&H”), part of H&H Group to develop products which are derived from whey and/or no-fat milk and have the potential to prevent allergies. The Agreement will follow a four-year development plan including pre-clinical and clinical milestones with the goal of reducing allergenicity or even preventing food (particularly milk) allergy in humans. The product(s) under development are based on the technology discovered by the French company Genclis SA (“Genclis”) that has established the role and consequences of Transcription Infidelity (TI) on allergy. This series of discoveries are the basis for their patent application referred to as the Molecular Origin of Allergy (WO 2017/158202) on which Relief has acquired in April 2018 a license for the development and commercialization of hypoallergenic milk produced without hydrolysis. The global allergy market that includes diagnostic and therapeutic, is currently growing at a 5.5% CAGR p...

Global Tamiflu (Oseltamivir Phosphate) Market Insights, Forecast to 2025

In this report, the Global Tamiflu (Oseltamivir Phosphate) market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Global Tamiflu (Oseltamivir Phosphate) market has been broken down by major regions, with complete market estimates on the basis of products/applications on a regional basis. Browse full research report at https://www.crystalmarketreport.com/global-tamiflu-oseltamivir-phosphate-market-insights-forecast-to-2025 Oseltamivir, sold under the brand name Tamiflu, is an antiviral medication used to treat and prevent influenza A and influenza B (flu). The global Tamiflu (Oseltamivir Phosphate) market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Tamiflu (Oseltamivir Phosphate) market based on company, product type, end user and key regions. This report studies the global market size of Tamiflu (Oseltamivir Phosphate) in key regions like North America, Europe, China and Japan, focuses on the consumption of Tamiflu (Osel...